Treatment with the cathepsin K inhibitor odanacatib in postmenopausal women with low BMD: 5 year results of a phase 2 trial
B. Langdahl⁎, N. Binkley, H. Bone, N. Gilchrist, H. Resch, J. Rodriguez Portales, A. Lombardi, A. Denker, C.L.B.D.T. Le Bailly De Tilleghem, C. DaSilva, E. Rosenberg, A. LeungVolume:
50
Year:
2012
Language:
english
Pages:
1
DOI:
10.1016/j.bone.2012.02.127
File:
PDF, 153 KB
english, 2012